Status:

COMPLETED

Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia

Lead Sponsor:

Movetis

Conditions:

Cirrhotic Ascites

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

M0002, an orally active, selective non-peptidergic antagonist of the vasopressin V2 receptor inhibits vasopressin-induced water reabsorption from the kidney. Therefore the aquaretic effect of M0002 ha...

Eligibility Criteria

Inclusion

  • Main
  • Subjects with any form of cirrhosis with ascites and who had at least 1 paracentesis of at least 4 liter in the last 6 months.
  • Dose of diuretics of spironolactone and furosemide was to be stable for at least one week prior to the screening visit or subject was refractory to diuretics.
  • Subjects had to have been on a salt restricted diet (\< 5.2 grams sodium/day, 90 mmol) during the screening period prior to the trial drug administration.
  • Other treatment for the management of cirrhosis and ascites should be stable for at least 2 weeks prior to trial drug administration.
  • Child-Pugh B and C liver cirrhosis score lower than 12.
  • Subjects with hyponatraemia with sodium level between 120 and 132 mmol/l or normonatraemia with sodium level between 133 and 145 mmol/l measured at screening visit and day 1.
  • Main

Exclusion

  • Women of child bearing potential (WOCBP)
  • Functional transjugular intrahepatic portasystemic stent shunt (TIPS), peritoneovenous shunt
  • Liver transplantation
  • Budd-Chiari syndrome
  • Unstable hepatic disease (acute hepatitis, AST or ALT \> 5 x upper limit of normal, bilirubin \> 10 mg/dL)

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2007

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01179607

Start Date

June 1 2007

End Date

December 1 2007

Last Update

August 11 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia | DecenTrialz